Table 1.
Weight loss outcomes of GLP-1RA and GLP-1/GIP RA in randomized clinical trials.
| GLP-1RA | 3 months | 6 months | 9 months | 12 months |
|---|---|---|---|---|
| Liraglutide 3.0 mg | 6 % | 8 % | 9 % | 9 % |
| Semaglutide 2.4 mg | 6 % | 10 % | 14 % | 15 % |
| Tirzepatide 15 mg | 8 % | 15 % | 18 % | 20 % |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.